Redefining Engagement: Trust, Technology, and Transformation
In rare disease, scale is limited, but impact is amplified. This panel explores how Sobi is translating omnichannel strategy into a highly coordinated operating model that delivers measurable, week-to-week impact across brands.
- Embedding omnichannel leadership directly within brand teams to ensure strategy is tightly aligned with real-time market dynamics and field execution
- Centralizing measurement across brands to create a consistent, scalable view of performance and enable faster cross-brand learning
- Integrating data science, CRM, and inside sales into a single operating rhythm to eliminate silos and accelerate execution
- Establishing a weekly data → insight → action cadence to move beyond static planning and enable continuous optimization
- Prioritizing high-value HCP and patient touchpoints where precision and personalization drive disproportionate impact in rare disease
Turning Strategy Into Seamless Execution
Direct-to-patient (DTP) platforms like Lilly Direct, Hims & Hers, and Ro aren't just expanding access, they're reshaping patient behavior and redefining expectations. Consumers increasingly look for healthcare experiences that reflect the speed, convenience, and personalization they encounter in other parts of their lives (like Amazon), where discovery, decision-making, and fulfillment unfold within a single, seamless journey. As care moves closer to ecommerce, marketers must evolve beyond traditional models.
- How social commerce, cash-pay models, and telehealth are converging to form a new, consumer-driven care journey
- What direct-to-patient platforms are doing effectively when it comes to engagement, trust-building, and behavior design
- How pharma marketers can evolve their strategies to better align with modern patient behaviors and expectations
Check out the incredible speaker line-up to see who will be joining Brittney.
Download The Latest Agenda